Adimab Announces Multi-Target Expansion for the Discovery of Antibodies with Another Global Pharma Partner
LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced…